Top Tweets for #APLAR20

Healthcare Hashtag Project @healthhashtags

almost 6 years ago

So many onDemand recorded sessions that i need (want) to (re)watch from #ACR20 #APLAR20 #LupusAcademy20 but right now i demand myself (another) coffee before i have to go to work.

0

2

0

APLAR @APLAR_org

almost 6 years ago

Thank you to each and every abstract submitter for submitting your latest research to the APLAR Congress. Without you, the future of rheumatology research would not be as bright. Take a look at the slides below to see the #APLAR20 Best Abstract Winners:

0

1

0

almost 6 years ago

Top Influencers of #APLAR20: @APLAR_org @_connectedcare @RHEUMarampa @rheumarhyme @drdavidliew @rheum_cat More 📊 https://t.co/7Adec6K2MX

2

3

0

APLAR @APLAR_org

almost 6 years ago

It’s a wrap! Thank you to all delegates, speakers, abstract submitters, sponsors and exhibitors for making #APLAR20 Virtual a roaring success. See you next year in historic #Kyoto, #Japan for another exciting edition of the APLAR Congress! https://t.co/87VquRuFgV

APLAR_org's tweet photo. It’s a wrap! Thank you to all delegates, speakers, abstract submitters, sponsors and exhibitors for making #APLAR20 Virtual a roaring success. See you next year in historic #Kyoto, #Japan for another exciting edition of the APLAR Congress! https://t.co/87VquRuFgV https://t.co/b9AYzYTcO6

0

7

1

0

almost 6 years ago

A BIG congratulations to the @APLAR_org organizing committee for the success of #APLAR20 👏👏 i still have topics to get back to but i deeply enjoyed watching the live sessions and tweeting about them 🤓

1

4

0

almost 6 years ago

Interesting talk by Prof. @okada_yukinori on #genetics in autoimmune dses. 😀 Using trans-ethnic MR, he explains how genetics can be used to develop novel therapeutic targets. #APLAR20

RHEUMarampa's tweet photo. Interesting talk by Prof. @okada_yukinori on #genetics in autoimmune dses. 😀 Using trans-ethnic MR, he explains how genetics can be used to develop novel therapeutic targets. #APLAR20 https://t.co/L0lgww1Axu

0

4

1

0

almost 6 years ago

And there it is... why #APLAR20 doesnt really trend like #EULAR20 and #ACR20 :( Update from Dr Yew Kuang Cheng

0

4

0

MyRheumatology @rheumatologymy

almost 6 years ago

Wonderful summary report of the #APLAR20 SIG groups & exciting plans up ahead for all. What's your local SIG group? @chardrheuma @trishiemd @nizie_victoria Im in #vasculitis #gout & #sle kasi automatik yung last part sa amin hahaha dba @RHEUMarampa. #goUSTe

2

3

0

almost 6 years ago

Real world data might be a whole lot different as medication adherence comes into play. #APLAR20 #upadacitinib

almost 6 years ago

SELECT-PsA: Upadacitinib effective & at 30mg dose, superiority met vs Adalimumab #APLAR20 but at this dose, more side effects

_connectedcare's tweet photo. SELECT-PsA: Upadacitinib effective & at 30mg dose, superiority met vs Adalimumab #APLAR20

but at this dose, more side effects https://t.co/yUZHEwPNfl

1

4

2

0

1

2

0

almost 6 years ago · Sydney

@savageeimear I know the western world has published studies on MMF and I’ve used it on one case as well. This was an #APLAR20 presentation by a Japanese group with a collection of patients. The Chinese professor in a prior talk uses Tofacitinib early.

0

4

0

almost 6 years ago

In this study, 7 pts developed #myositis in the peripartum period. What could be the risk factors associated with poor pregnancy outcomes? @LatikaGupta_ Great talk by the way! #APLAR20

RHEUMarampa's tweet photo. In this study, 7 pts developed #myositis in the peripartum period. What could be the risk factors associated with poor pregnancy outcomes? @LatikaGupta_ Great talk by the way! #APLAR20 https://t.co/YRAz5qA7SQ

0

9

2

0

almost 6 years ago

Systemic #sclerosis is a very challenging disease and pregnancy should always be planned. Maternal complications like hypertensive disorders include #eclampsia & #scleroderma renal crisis @LatikaGupta_ #APLAR20

RHEUMarampa's tweet photo. Systemic #sclerosis is a very challenging disease and pregnancy should always be planned. Maternal complications like hypertensive disorders include #eclampsia & #scleroderma renal crisis @LatikaGupta_ #APLAR20 https://t.co/l0jCiIDJKF

0

15

3

0

almost 6 years ago

Treatment strategy for ILD associated with anti-MDA5+ Dermatomyositis. No great evidence base but aggressive given how difficult to treat this is. Here's some Japanese recommendations #APLAR20

_connectedcare's tweet photo. Treatment strategy for ILD associated with anti-MDA5+ Dermatomyositis.

No great evidence base but aggressive given how difficult to treat this is. Here's some Japanese recommendations #APLAR20 https://t.co/bSwNlfTKhQ

4

46

17

6

0

almost 6 years ago

anti-MDA5 positive DM with interstitial lung disease is nasty #APLAR20

0

14

10

1

0

almost 6 years ago

#APLAR20 Dr Arvind Chopra asks what's missing in the copcord: riskfactors, #healthEducation strategies, studies on burden and economics, long term studies that can actually serve the #community.

rheumarhyme's tweet photo. #APLAR20 Dr Arvind Chopra asks what's missing in the copcord: riskfactors, #healthEducation strategies, studies on burden and economics, long term studies that can actually serve the #community. https://t.co/RNYFPsCk1Z

0

2

0

almost 6 years ago

Good to see IL-23 inhibition, Guselkumab, may have efficacy on inflammatory spinal disease (post-hoc analysis of PsA trials) #APLAR20

_connectedcare's tweet photo. Good to see IL-23 inhibition, Guselkumab, may have efficacy on inflammatory spinal disease (post-hoc analysis of PsA trials)

#APLAR20 https://t.co/YhtaezYPOw

0

3

0

almost 6 years ago

SELECT-PsA: Upadacitinib effective & at 30mg dose, superiority met vs Adalimumab #APLAR20 but at this dose, more side effects

1

4

2

0

almost 6 years ago

The NAIL #APLAR20

0

13

1

0